307
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Factors Affecting Awareness of Pregnancy Screening for Group B Streptococcus Infection Among Women of Reproductive Age in Jazan Province, Saudi Arabia

, ORCID Icon, , , ORCID Icon, , , , , , & ORCID Icon show all
Pages 2109-2116 | Received 15 May 2023, Accepted 17 Jul 2023, Published online: 26 Jul 2023

References

  • Almohaimeed M, Al-Arfaj G, Kofi MA. Awareness of primary care physicians about pregnancy screening of group B Streptococcus infection at prince sultan military Medical City, Riyadh, Saudi Arabia. Int J Adv Community Med. 2019;2:23–29. doi:10.33545/comed.2019.v2.i1a.06
  • Tevdorashvili G, Tevdorashvili D, Andghuladze M, Tevdorashvili M. Prevention and treatment strategy in pregnant women with group B streptococcal infection. Georgian Med News. 2015;25953932:15–23.
  • Alshengeti A, Alharbi A, Alraddadi S, Alawfi A, Aljohani B. Knowledge, attitude and current practices of pregnant women towards group B streptococcus screening: cross-sectional study, Al-Madinah, Saudi Arabia. BMJ Open. 2020;10(2):e032487. doi:10.1136/bmjopen-2019-032487
  • Santhanam S, Arun S, Rebekah G, et al. Perinatal risk factors for neonatal early-onset group B Streptococcal sepsis after initiation of risk-based maternal intrapartum antibiotic prophylaxis—a case control study. J Trop Pediatr. 2018;64(4):312–316. doi:10.1093/tropej/fmx068
  • Musleh J, Al Qahtani N. Group B Streptococcus colonization among Saudi women during labor. Saudi J Med Med Sci. 2018;6:18. doi:10.4103/sjmms.sjmms_175_16
  • Burcham LR, Spencer BL, Keeler LR, et al. Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women. PLoS One. 2019;14(12):e0226699. doi:10.1371/journal.pone.0226699
  • Alamri Y, Albasri S, Abduljabbar GH, Alghamdi H, Balkhair AM, AlAam R. Awareness of pregnancy screening for Group B Streptococcus infection among women of reproductive age and physicians in Jeddah, Saudi Arabia. Cureus. 2021. doi:10.7759/cureus.18765
  • Hanna M, Noor A. Streptococcus Group B; 2023.
  • Mei JY, Silverman NS. Group B Streptococcus in pregnancy. Obstet Gynecol Clin. 2023;50(2):375–387. doi:10.1016/j.ogc.2023.02.009
  • Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect. 2014;68:S24–S32. doi:10.1016/j.jinf.2013.09.011
  • Gopal Rao G, Nartey G, McAree T, et al. Outcome of a screening programme for the prevention of neonatal invasive early-onset group B Streptococcus infection in a UK maternity unit: an observational study. BMJ Open. 2017;7(4):e014634. doi:10.1136/bmjopen-2016-014634
  • Almudeer AH, Alibrahim MA, Gosadi IM. Epidemiology and risk factors associated with early onset neonatal sepsis in the south of KSA. J Taibah Univ Medical Sci. 2020;15(6):509–514. doi:10.1016/j.jtumed.2020.08.009
  • Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J Pediatr. 2020;96:80–86. doi:10.1016/j.jped.2019.10.004
  • Schrag SJ, Verani JR. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine. Vaccine. 2013;31:D20–D26. doi:10.1016/j.vaccine.2012.11.056
  • Berardi A, Spada C, Vaccina E, Boncompagni A, Bedetti L, Lucaccioni L. Intrapartum beta-lactam antibiotics for preventing group B streptococcal early-onset disease: can we abandon the concept of ‘inadequate’ intrapartum antibiotic prophylaxis? Expert Rev Anti Infect Ther. 2020;18(1):37–46. doi:10.1080/14787210.2020.1697233
  • Goel N, Wattal C, Gujral K, Dhaduk N, Mansukhani C, Garg P. Group B Streptococcus in Indian pregnant women: its prevalence and risk factors. Indian J Med Microbiol. 2020;38(3–4):357–361. doi:10.4103/ijmm.IJMM_20_333
  • Vornhagen J, Waldorf KM, Rajagopal L. Perinatal group B streptococcal infections: virulence factors, immunity, and prevention strategies. Trends Microbiol. 2017;25(11):919–931. doi:10.1016/j.tim.2017.05.013
  • Berardi A, Trevisani V, Di Caprio A, et al. Understanding factors in group B Streptococcus late-onset disease. Infect Drug Resist. 2021;17:3207–3218. doi:10.2147/IDR.S291511
  • Zhu Y, Lin XZ. Updates in prevention policies of early-onset group B streptococcal infection in newborns. Pediatr Neonatol. 2021;62(5):465–475. doi:10.1016/j.pedneo.2021.05.007
  • Gopal Rao G, Hiles S, Bassett P, Lamagni T. Differential rates of group B streptococcus (GBS) colonisation in pregnant women in a racially diverse area of London, UK: a cross‐sectional study. BJOG. 2019;126(11):1347–1353. doi:10.1111/1471-0528.15648
  • de Mello DS, Tsunechiro MA, Mendelski CA, et al. Group B Streptococcus: compliance with the information in prenatal card records and knowledge of pregnant women. Am J Infect Control. 2015;43(4):400–401. doi:10.1016/j.ajic.2014.12.026
  • Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013;31:D3–D6. doi:10.1016/j.vaccine.2013.02.030